miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5

Table 4

The relationship between miR-370-3p in exosomes of breast cancer serum and clinicopathological parameters.

Clinicopathological information	n	Relative expression of miR-370-3p	P
Tumor diameter
<=2cm	15	0.239(0.184, 0.337)	0.0429
>2cm	12	0.389(0.268, 0.514)
Age
<=50	7	0.279(0.182, 0.344)	0.3911
>50	20	0.324(0.211, 0.437)
Pathological type
Ductal carcinoma in situ	2	0.553(0.258, 0.572)	0.1583
Invasive ductal carcinoma	8	0.379(0.210, 0.478)
Invasive cancer	14	0.248(0.162, 0.321)
Others	3	0.351(0.153, 0.374)
Lymph node metastasis
0	18	0.247(0.174, 0.339)	0.0193
>=1	9	0.401(0.308, 0.485)
TNM staging
I	13	0.237(0.184, 0.322)	0.0273
II	14	0.376(0.238, 0.513)